Janssen applies for FDA approval for Genmab drug
![Photo: Tuala Hjarnø / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13383397.ece/ALTERNATES/schema-16_9/doc7i1a4vt0dk714w5ed2v9.jpg)
Genmab's partner Janssen has applied for approval for its bone marrow cancer treatment teclistamab from the US Food and Drug Administration (FDA).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA approves another Darzalex combination treatment
For subscribers